Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
Medtronic
Cantor Fitzgerald
Citi
Harvard Business School
Cerilliant
Merck
Moodys

Generated: October 19, 2018

DrugPatentWatch Database Preview

Indivior Inc Company Profile

« Back to Dashboard

What is the competitive landscape for INDIVIOR INC, and what generic alternatives to INDIVIOR INC drugs are available?

INDIVIOR INC has six approved drugs.

There are seventeen US patents protecting INDIVIOR INC drugs.

Summary for Indivior Inc
US Patents:17
Tradenames:5
Ingredients:4
NDAs:6
Patent Litigation for Indivior Inc: See patent lawsuits for Indivior Inc

Drugs and US Patents for Indivior Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Indivior Inc SUBOXONE buprenorphine hydrochloride; naloxone hydrochloride FILM;BUCCAL, SUBLINGUAL 022410-004 Aug 10, 2012 AB RX Yes Yes 9,687,454 ➤ Sign Up Y ➤ Sign Up
Indivior Inc PERSERIS KIT risperidone FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS 210655-002 Jul 27, 2018 RX Yes Yes 9,186,413 ➤ Sign Up ➤ Sign Up
Indivior Inc SUBOXONE buprenorphine hydrochloride; naloxone hydrochloride FILM;BUCCAL, SUBLINGUAL 022410-002 Aug 30, 2010 AB RX Yes No 9,931,305 ➤ Sign Up Y ➤ Sign Up
Indivior Inc PERSERIS KIT risperidone FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS 210655-001 Jul 27, 2018 RX Yes No 10,058,554 ➤ Sign Up ➤ Sign Up
Indivior Inc SUBOXONE buprenorphine hydrochloride; naloxone hydrochloride FILM;BUCCAL, SUBLINGUAL 022410-001 Aug 30, 2010 AB RX Yes No 8,603,514 ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for INDIVIOR INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Sublingual Film 4 mg/1 mg ➤ Subscribe 2013-05-14
➤ Subscribe Sublingual Film 2 mg/0.5 mg and 8 mg/2 mg ➤ Subscribe 2012-10-15
➤ Subscribe Sulingual Film 12 mg/3 mg ➤ Subscribe 2014-03-26

Supplementary Protection Certificates for Indivior Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0008 Belgium ➤ Sign Up PRODUCT NAME: RISPERIDONE; NAT REG.: 2 S 414 F 3 19940527; FIRST REG.: GB 0242/0186 19921208
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Chinese Patent Office
McKinsey
Express Scripts
Fish and Richardson
Boehringer Ingelheim
Cipla
Accenture
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.